2000
DOI: 10.1099/00221287-146-4-957
|View full text |Cite
|
Sign up to set email alerts
|

A Clostridium difficile gene encoding flagellin The GenBank accession numbers for the sequences reported in this paper are AF065259 (strain 79-685) and AF077341 (strain VPI 10463).

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
36
0
1

Year Published

2001
2001
2017
2017

Publication Types

Select...
7
2
1

Relationship

1
9

Authors

Journals

citations
Cited by 53 publications
(37 citation statements)
references
References 56 publications
0
36
0
1
Order By: Relevance
“…However, not all C. difficile-associated disease is caused by toxigenic strains of C. difficile (5,8,14,46,47). Thus, other virulence factors, such as adhesins, are likely important in the pathogenesis of C. difficile-associated disease.…”
Section: Discussionmentioning
confidence: 99%
“…However, not all C. difficile-associated disease is caused by toxigenic strains of C. difficile (5,8,14,46,47). Thus, other virulence factors, such as adhesins, are likely important in the pathogenesis of C. difficile-associated disease.…”
Section: Discussionmentioning
confidence: 99%
“…releasing suitable substrates from available protein sources for metabolism and which could be involved in mucus penetration (Poilane et al, 1998 ;Seddon & Borriello, 1992) ; (iii) adhesins, which are involved in mucus and cell association (Borriello et al, 1988a ;Eveillard et al, 1993 ;Karjalainen et al, 1994) ; (iv) fimbriae, the role of which is obscure (Borriello et al, 1988a) ; and (v) flagella, for which no role in C. difficile colonization has yet been assigned (Tasteyre et al, 2000).…”
Section: Abbreviationsmentioning
confidence: 99%
“…The fliC, fliD and cwp84 genes were PCR-amplified from an ermB, Clin r , ribotype 001, North American pulsotype 2 C. difficile Calgary Laboratory Services clinical isolate # 2007 provided by Dr Thomas Louie (Department of Medicine, University of Calgary). The PCR primers were designed as described previously (Savariau-Lacomme et al, 2003;Tasteyre et al, 2000Tasteyre et al, , 2001b but lacking the 59 restriction sites. Next, the PCR products were cloned into pQE-30 UA (Qiagen) following the manufacturer's instructions.…”
Section: Methodsmentioning
confidence: 99%